World Intellectual Property Organization

Canada

Regulations Amending the Patented Medicines (Notice of Compliance) Regulations

Shortcuts

Canada

Year of current version:2008
Date of Text (Issued):June 12, 2008
Type of Text:Implementing Rules/Regulations
Subject Matter:Enforcement of IP and Related Laws, Industrial Property, IP Regulatory Body, Patents (Inventions)
Notes:
Date of entry into force: See Article 5

The notification by Canada to the WTO under Article 63.2 of TRIPS states:
'These Regulations reinforce the predictability, stability and competitiveness of Canada’s intellectual property (IP) regime for pharmaceuticals by reaffirming and clarifying the intended effect of a transitional measure included in an earlier round of amendments to the same instrument. The intention of that measure was to ensure that patents eligible for protection under the Regulations as they were prior to October 5, 2006 remain so until expiry.'
Available Texts: 
English

Regulations Amending the Patented Medicines (Notice of Compliance) Regulations Regulations Amending the Patented Medicines (Notice of Compliance) Regulations, Complete document (pdf) [39 KB]

French

Règlement modifiant le Règlement sur les médicaments brevetés (Avis de conformité) Règlement modifiant le Règlement sur les médicaments brevetés (Avis de conformité), Complete document (pdf) [28 KB]

Related Legislation:
WIPO Lex No.:CA056

Explore WIPO